XML 39 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Organization - Additional Information (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Nov. 30, 2020
Mar. 31, 2023
Jan. 01, 2023
Dec. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Aggregate offering price $ 300,000      
Retained earnings   $ 236,337   $ 377,237
Cash, cash equivalents and investments   $ 2,300,000    
Encentrio Therapeutics, Inc. [Member]        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Percentage of outstanding voting shares owned     80.00%  
Common Stock | Sales Agreement        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Issuance of common stock (in shares)   0    
Percentage of commission rate from sale of shares 3.00%